SE401673B - Forfarande for framstellning av 2-substituerade 5-sulfamyl-bensoesyror med plasmalipidsenkande verkan - Google Patents
Forfarande for framstellning av 2-substituerade 5-sulfamyl-bensoesyror med plasmalipidsenkande verkanInfo
- Publication number
- SE401673B SE401673B SE7111587A SE1158771A SE401673B SE 401673 B SE401673 B SE 401673B SE 7111587 A SE7111587 A SE 7111587A SE 1158771 A SE1158771 A SE 1158771A SE 401673 B SE401673 B SE 401673B
- Authority
- SE
- Sweden
- Prior art keywords
- plasmalipide
- sulfamyl
- substituted
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7215670A | 1970-09-14 | 1970-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE401673B true SE401673B (sv) | 1978-05-22 |
Family
ID=22105942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7111587A SE401673B (sv) | 1970-09-14 | 1971-09-13 | Forfarande for framstellning av 2-substituerade 5-sulfamyl-bensoesyror med plasmalipidsenkande verkan |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5512422B1 (xx) |
| AT (1) | AT323187B (xx) |
| AU (1) | AU468590B2 (xx) |
| BE (1) | BE772381A (xx) |
| CA (1) | CA983489A (xx) |
| CH (2) | CH552575A (xx) |
| ES (2) | ES394830A1 (xx) |
| FR (1) | FR2106514B1 (xx) |
| GB (1) | GB1353357A (xx) |
| KE (1) | KE2573A (xx) |
| MY (1) | MY7500253A (xx) |
| NL (1) | NL173400C (xx) |
| SE (1) | SE401673B (xx) |
| ZA (1) | ZA715851B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929803A (en) * | 1974-05-28 | 1975-12-30 | Pfizer | Aryl carboxylic acids |
| WO1983000013A1 (en) * | 1980-11-10 | 1983-01-06 | Mochida Pharm Co Ltd | Medicinal composition having an antiviral effect |
| SE8203877L (sv) * | 1981-06-22 | 1982-12-23 | Hodogaya Chemical Co Ltd | Aminosulfonylbensoesyraderivat |
| EP0132540A1 (en) * | 1981-06-22 | 1985-02-13 | Mochida Pharmaceutical Co., Ltd. | Antiviral compositions |
| JPS58192863A (ja) * | 1982-05-06 | 1983-11-10 | Hodogaya Chem Co Ltd | 新規アミノスルホニル安息香酸エステル誘導体 |
| JPS6323210U (xx) * | 1986-07-31 | 1988-02-16 | ||
| DE3732374A1 (de) * | 1987-09-25 | 1989-04-06 | Basf Lacke & Farben | Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel |
| JPH0248510U (xx) * | 1988-09-28 | 1990-04-04 | ||
| EP1218341B1 (de) * | 1999-09-01 | 2005-08-24 | Aventis Pharma Deutschland GmbH | Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE19941559A1 (de) * | 1999-09-01 | 2001-03-15 | Aventis Pharma Gmbh | Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH433378A (de) * | 1962-03-09 | 1967-04-15 | Ciba Geigy | Verfahren zur Herstellung neuer Anthranilsäurederivate |
| FR1525352A (fr) * | 1967-04-06 | 1968-05-17 | Ile De France | Procédé de préparation des acides 2-alcoxy-5-sulfamido-benzoïques |
-
1971
- 1971-04-19 GB GB2654071*A patent/GB1353357A/en not_active Expired
- 1971-08-31 CA CA121,776A patent/CA983489A/en not_active Expired
- 1971-09-01 ZA ZA715851A patent/ZA715851B/xx unknown
- 1971-09-03 AU AU33084/71A patent/AU468590B2/en not_active Expired
- 1971-09-06 ES ES394830A patent/ES394830A1/es not_active Expired
- 1971-09-09 BE BE772381A patent/BE772381A/xx not_active IP Right Cessation
- 1971-09-13 SE SE7111587A patent/SE401673B/xx unknown
- 1971-09-13 CH CH1338771A patent/CH552575A/fr not_active IP Right Cessation
- 1971-09-13 AT AT793171A patent/AT323187B/de not_active IP Right Cessation
- 1971-09-13 CH CH128873A patent/CH569706A5/xx not_active IP Right Cessation
- 1971-09-14 FR FR7133085A patent/FR2106514B1/fr not_active Expired
- 1971-09-14 NL NLAANVRAGE7112598,A patent/NL173400C/xx not_active IP Right Cessation
- 1971-09-14 JP JP7163471A patent/JPS5512422B1/ja active Pending
-
1973
- 1973-10-15 KE KE2573*UA patent/KE2573A/xx unknown
-
1974
- 1974-01-02 ES ES421977A patent/ES421977A1/es not_active Expired
-
1975
- 1975-12-30 MY MY253/75A patent/MY7500253A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH569706A5 (xx) | 1975-11-28 |
| AT323187B (de) | 1975-06-25 |
| ES421977A1 (es) | 1976-05-01 |
| BE772381A (fr) | 1972-03-09 |
| GB1353357A (en) | 1974-05-15 |
| MY7500253A (en) | 1975-12-31 |
| ZA715851B (en) | 1972-05-31 |
| AU468590B2 (en) | 1976-01-15 |
| DE2145686B2 (de) | 1977-07-07 |
| FR2106514A1 (xx) | 1972-05-05 |
| KE2573A (en) | 1975-10-31 |
| NL173400B (nl) | 1983-08-16 |
| NL173400C (nl) | 1984-01-16 |
| FR2106514B1 (xx) | 1975-08-01 |
| CA983489A (en) | 1976-02-10 |
| NL7112598A (xx) | 1972-03-16 |
| AU3308471A (en) | 1973-03-08 |
| JPS5512422B1 (xx) | 1980-04-02 |
| ES394830A1 (es) | 1974-12-01 |
| DE2145686A1 (de) | 1972-04-20 |
| CH552575A (fr) | 1974-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE401504B (sv) | Forfarande for framstellning av diaryl-imidazoler med inflammationsinhiberande effekt | |
| SE393381B (sv) | Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat | |
| SE393800B (sv) | Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt | |
| FI56686B (fi) | Foerfarande foer framstaellning av 7-aminocefalosporansyraderivat med antibiotis verkan | |
| SE389670B (sv) | Forfarande for framstellning av aroyl-substituerade pyrroler med terapeutisk verkan | |
| SE417205B (sv) | Forfarande for framstellning av foreningar med autibiotisk verkan | |
| SE385885B (sv) | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat | |
| SE394678B (sv) | Analogiforfarande for framstellning av pyridokinolinderivat | |
| SE405599B (sv) | Forfarande for framstellning av pyridazinoner med terapeutisk verkan | |
| NO138883C (no) | Fremgangsmaate for fremstilling av oksiranforbindelser | |
| SE397677B (sv) | Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra | |
| SE380522B (sv) | Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan | |
| SE399701B (sv) | Forfarande for framstellning av hydroxyalkyldiamin | |
| SE405477B (sv) | Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan | |
| SE403911B (sv) | Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan | |
| SE401673B (sv) | Forfarande for framstellning av 2-substituerade 5-sulfamyl-bensoesyror med plasmalipidsenkande verkan | |
| SE394436B (sv) | Forfarande for framstellning av 7-halogen-linkomyciner | |
| SE395892B (sv) | Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan | |
| SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
| SE395897B (sv) | Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror | |
| SE385011B (sv) | Forfarande for framstellning av alfa-linkosaminider | |
| SE395699B (sv) | Forfarande for framstellning av kinuklidin-kinolinderivat | |
| SE408418B (sv) | Forfarande for framstellning av 5-fluor-pyrimidiner | |
| SE380517B (sv) | Forfarande for framstellning av fluoren-2-ettiksyraderivat med antiinflammatorisk verkan | |
| SE380795B (sv) | Forfarande for framstellning av tiokarbamider |